Does Methotrexate Cause Long-Term Side Effects?
Yes, methotrexate, used for rheumatoid arthritis, psoriasis, and cancer, carries risks of long-term side effects with prolonged use, especially at higher doses. These stem from its interference with folate metabolism and rapid cell division, affecting bone marrow, liver, lungs, and other organs. Monitoring via blood tests is standard to catch issues early.[1][2]
What Liver Problems Can Develop Over Time?
Chronic liver toxicity is the most common long-term concern, progressing from fatty liver to fibrosis or cirrhosis after years of use. Risk rises with daily low-dose therapy (e.g., for RA) and factors like alcohol use or obesity. Up to 15-20% of patients show liver enzyme elevations; biopsies occasionally reveal advanced damage. Folic acid supplementation reduces but doesn't eliminate this risk.[1][3]
How Does It Affect the Lungs Long-Term?
Pulmonary fibrosis or pneumonitis can emerge after months to years, even at low doses. Symptoms include dry cough and shortness of breath. Incidence is low (1-5% in RA patients), but it's irreversible in some cases and may require stopping the drug. Smokers face higher odds.[2][4]
Are There Bone Marrow or Blood Risks with Extended Use?
Methotrexate suppresses bone marrow, leading to chronic anemia, leukopenia, or thrombocytopenia. Long-term, this increases infection risk and may cause pancytopenia. Regular complete blood counts detect this; recovery often follows dose reduction.[1][3]
What About Cancer Risks from Years of Treatment?
There's debate over oncogenicity. It may slightly elevate skin cancer or lymphoma risk in autoimmune patients, possibly due to immunosuppression rather than the drug alone. Studies show no clear increase in solid tumors, but surveillance is advised.[2][5]
Fertility and Pregnancy Concerns for Long-Term Users
In men, it can cause reversible infertility or sperm abnormalities; oligospermia resolves after stopping. Women risk ovarian failure or birth defects if pregnant during use—teratogenic effects persist months post-discontinuation. Contraception is mandatory.[1][4]
Who Faces Higher Long-Term Risks?
Patients with diabetes, obesity, heavy alcohol intake, or kidney issues see amplified effects due to slower drug clearance. Elderly users and those on combo therapies (e.g., with NSAIDs) need closer monitoring. Genetic factors like MTHFR mutations may heighten toxicity.[3][5]
How Do Doctors Manage These Risks?
Baseline and periodic tests (liver enzymes, blood counts, creatinine) every 1-3 months guide adjustments. Low weekly dosing (7.5-25 mg for RA) minimizes harm versus daily high doses for cancer. Alternatives like biologics are considered if toxicity appears.[2][4]
[1]: Mayo Clinic - Methotrexate (oral route)
[2]: UpToDate - Methotrexate: Overview of adverse effects
[3]: American College of Rheumatology - Methotrexate Guidelines
[4]: NHS - Methotrexate Side Effects
[5]: PubMed - Long-term safety of methotrexate